AKT1 and Alzheimer disease: Several studies of postmortem brains of AD patients have indicated that insulin/IGF-1 resistance, along with aberrant activation of the PI3K/Akt pathway, leads to the overactivation of GSK-3β and reduced insulin/IGF-1 levels (which act as neurotrophic factors) [10,45,46,47].